Bio-Rad Laboratories Quarterly Income Statements Chart
Quarterly
|
Annual
Bio-Rad Laboratories Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net sales | 651,600,000 | 585,400,000 | 667,475,000 | 649,729,000 | 638,476,000 | 610,820,000 | 681,184,000 | 632,124,000 | 681,110,000 | 676,844,000 | 730,288,000 | 680,800,000 | 691,099,000 | 700,062,000 | 732,769,000 | 747,049,000 | 715,931,000 | 726,796,000 | 789,839,000 | 647,263,000 | 536,880,000 | 571,644,000 | 624,428,000 | 560,633,000 | 572,619,000 | 553,979,000 | 616,847,000 | 545,138,000 | 575,911,000 | 551,519,000 | 620,433,000 | 535,003,000 | 504,666,000 | 500,051,000 | 571,453,000 | 508,745,000 | 516,777,000 | 471,197,000 | 570,557,000 | 469,961,000 | 506,102,000 | 472,821,000 | 598,224,000 | 530,644,000 | 536,832,000 | 509,344,000 | 602,635,000 | 505,066,000 | 525,321,000 | 499,672,000 | 573,839,000 | 498,697,000 | 510,422,000 | 486,277,000 | 550,238,000 | 516,514,000 | 521,656,000 | 422,197,000 | 339,742,000 | 339,114,000 |
| cost of goods sold | 306,300,000 | 279,400,000 | 325,563,000 | 293,826,000 | 283,357,000 | 284,854,000 | 314,821,000 | 296,441,000 | 318,627,000 | 314,427,000 | 336,291,000 | 307,008,000 | 295,118,000 | 296,502,000 | 331,768,000 | 309,614,000 | 314,333,000 | 326,169,000 | 329,684,000 | 279,952,000 | 243,892,000 | 254,276,000 | 293,989,000 | 253,607,000 | 264,850,000 | 242,217,000 | 284,282,000 | 258,422,000 | 274,244,000 | 249,316,000 | 280,840,000 | 230,483,000 | 231,367,000 | 230,064,000 | 257,096,000 | 229,276,000 | 236,545,000 | 207,168,000 | 262,042,000 | 206,509,000 | 226,505,000 | 202,715,000 | 280,814,000 | 242,068,000 | 239,590,000 | 234,055,000 | 279,886,000 | 220,850,000 | 225,220,000 | 228,260,000 | 259,693,000 | 225,187,000 | 222,522,000 | 207,695,000 | 239,272,000 | 220,338,000 | 228,520,000 | 195,314,000 | 151,385,000 | 149,123,000 |
| gross profit | 345,300,000 | 306,000,000 | 341,912,000 | 355,903,000 | 355,119,000 | 325,966,000 | 366,363,000 | 335,683,000 | 362,483,000 | 362,417,000 | 393,997,000 | 373,792,000 | 395,981,000 | 403,560,000 | 401,001,000 | 437,435,000 | 401,598,000 | 400,627,000 | 460,155,000 | 367,311,000 | 292,988,000 | 317,368,000 | 330,439,000 | 307,026,000 | 307,769,000 | 311,762,000 | 332,565,000 | 286,716,000 | 301,667,000 | 302,203,000 | 339,593,000 | 304,520,000 | 273,299,000 | 269,987,000 | 314,357,000 | 279,469,000 | 280,232,000 | 264,029,000 | 308,515,000 | 263,452,000 | 279,597,000 | 270,106,000 | 317,410,000 | 288,576,000 | 297,242,000 | 275,289,000 | 322,749,000 | 284,216,000 | 300,101,000 | 271,412,000 | 314,146,000 | 273,510,000 | 287,900,000 | 278,582,000 | 310,966,000 | 296,176,000 | 293,136,000 | 226,883,000 | 188,357,000 | 189,991,000 |
| yoy | -2.76% | -6.13% | -6.67% | 6.02% | -2.03% | -10.06% | -7.01% | -10.20% | -8.46% | -10.20% | -1.75% | -14.55% | -1.40% | 0.73% | -12.86% | 19.09% | 37.07% | 26.23% | 39.26% | 19.64% | -4.80% | 1.80% | -0.64% | 7.08% | 2.02% | 3.16% | -2.07% | -5.85% | 10.38% | 11.93% | 8.03% | 8.96% | -2.47% | 2.26% | 1.89% | 6.08% | 0.23% | -2.25% | -2.80% | -8.71% | -5.94% | -1.88% | -1.65% | 1.53% | -0.95% | 1.43% | 2.74% | 3.91% | 4.24% | -2.57% | 1.02% | -7.65% | -1.79% | 22.79% | 65.09% | 55.89% | ||||
| qoq | 12.84% | -10.50% | -3.93% | 0.22% | 8.94% | -11.03% | 9.14% | -7.39% | 0.02% | -8.02% | 5.41% | -5.60% | -1.88% | 0.64% | -8.33% | 8.92% | 0.24% | -12.94% | 25.28% | 25.37% | -7.68% | -3.96% | 7.63% | -0.24% | -1.28% | -6.26% | 15.99% | -4.96% | -0.18% | -11.01% | 11.52% | 11.42% | 1.23% | -14.11% | 12.48% | -0.27% | 6.14% | -14.42% | 17.10% | -5.77% | 3.51% | -14.90% | 9.99% | -2.92% | 7.97% | -14.70% | 13.56% | -5.29% | 10.57% | -13.60% | 14.86% | -5.00% | 3.34% | -10.41% | 4.99% | 1.04% | 29.20% | 20.45% | -0.86% | |
| gross margin % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative expense | 207,700,000 | 208,800,000 | 203,958,000 | 200,440,000 | 194,719,000 | 214,883,000 | 207,147,000 | 201,199,000 | 207,824,000 | 225,553,000 | 210,454,000 | 211,047,000 | 208,730,000 | 197,594,000 | 224,146,000 | 216,150,000 | 213,425,000 | 225,853,000 | 219,148,000 | 198,165,000 | 189,262,000 | 193,692,000 | 214,165,000 | 201,622,000 | 201,257,000 | 207,581,000 | 214,032,000 | 201,196,000 | 210,425,000 | 209,130,000 | 204,206,000 | 196,769,000 | 213,027,000 | 194,940,000 | 220,020,000 | 201,452,000 | 205,536,000 | 189,716,000 | 193,145,000 | 187,445,000 | 192,845,000 | 188,555,000 | 207,537,000 | 202,550,000 | 195,838,000 | 202,275,000 | 214,584,000 | 202,238,000 | 195,331,000 | 185,917,000 | 189,075,000 | 160,274,000 | 162,256,000 | 171,293,000 | 174,924,000 | 176,867,000 | 176,740,000 | 139,655,000 | 117,687,000 | 119,551,000 |
| research and development expense | 60,500,000 | 73,500,000 | 79,624,000 | 90,997,000 | 58,904,000 | 66,375,000 | 63,899,000 | 43,535,000 | 65,042,000 | 74,951,000 | 57,363,000 | 69,949,000 | 67,034,000 | 62,543,000 | 69,873,000 | 64,481,000 | 63,391,000 | 73,912,000 | 65,765,000 | 59,546,000 | 51,984,000 | 49,303,000 | 57,069,000 | 47,944,000 | 50,122,000 | 47,575,000 | 53,074,000 | 49,245,000 | 47,450,000 | 49,427,000 | 76,818,000 | 61,372,000 | 62,623,000 | 49,488,000 | 55,183,000 | 49,924,000 | 52,171,000 | 48,586,000 | 55,887,000 | 43,336,000 | 46,547,000 | 47,202,000 | 59,287,000 | 52,786,000 | 55,717,000 | 52,543,000 | 55,848,000 | 52,920,000 | 53,224,000 | 51,941,000 | 59,777,000 | 49,004,000 | 52,336,000 | 52,923,000 | 50,112,000 | 45,387,000 | 48,210,000 | |||
| income from operations | 77,100,000 | 23,700,000 | 58,330,000 | 64,466,000 | 101,496,000 | 44,708,000 | 95,317,000 | 90,949,000 | 89,617,000 | 61,913,000 | 126,180,000 | 92,796,000 | 120,217,000 | 143,423,000 | 106,982,000 | 156,804,000 | 124,782,000 | 100,862,000 | 175,242,000 | 109,600,000 | 51,742,000 | 74,373,000 | 59,205,000 | 57,460,000 | 56,390,000 | 56,606,000 | -227,054,000 | 36,275,000 | 43,792,000 | 43,646,000 | 47,063,000 | 46,379,000 | -2,351,000 | 25,559,000 | -23,151,000 | 28,093,000 | 22,525,000 | 25,727,000 | 59,483,000 | 32,671,000 | 40,205,000 | 34,349,000 | 50,586,000 | 33,240,000 | 45,687,000 | 20,471,000 | 52,317,000 | 29,058,000 | 51,546,000 | 33,554,000 | 65,294,000 | 64,232,000 | 73,308,000 | 54,366,000 | 85,930,000 | 73,922,000 | 68,186,000 | |||
| yoy | -24.04% | -46.99% | -38.80% | -29.12% | 13.26% | -27.79% | -24.46% | -1.99% | -25.45% | -56.83% | 17.95% | -40.82% | -3.66% | 42.20% | -38.95% | 43.07% | 141.16% | 35.62% | 195.99% | 90.74% | -8.24% | 31.39% | -126.08% | 58.40% | 28.77% | 29.69% | -582.45% | -21.79% | -1962.70% | 70.77% | -303.29% | 65.09% | -110.44% | -0.65% | -138.92% | -14.01% | -43.97% | -25.10% | 17.59% | -1.71% | -12.00% | 67.79% | -3.31% | 14.39% | -11.37% | -38.99% | -19.87% | -54.76% | -29.69% | -38.28% | -24.01% | -13.11% | 7.51% | |||||||
| qoq | 225.32% | -59.37% | -9.52% | -36.48% | 127.02% | -53.10% | 4.80% | 1.49% | 44.75% | -50.93% | 35.98% | -22.81% | -16.18% | 34.06% | -31.77% | 25.66% | 23.72% | -42.44% | 59.89% | 111.82% | -30.43% | 25.62% | 3.04% | 1.90% | -0.38% | -124.93% | -725.92% | -17.17% | 0.33% | -7.26% | 1.47% | -2072.74% | -109.20% | -210.40% | -182.41% | 24.72% | -12.45% | -56.75% | 82.07% | -18.74% | 17.05% | -32.10% | 52.18% | -27.24% | 123.18% | -60.87% | 80.04% | -43.63% | 53.62% | -48.61% | 1.65% | -12.38% | 34.84% | -36.73% | 16.24% | 8.41% | ||||
| operating margin % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| interest expense | 12,600,000 | 12,000,000 | 12,185,000 | 12,174,000 | 12,264,000 | 12,277,000 | 12,361,000 | 12,398,000 | 12,343,000 | 12,337,000 | 11,683,000 | 11,663,000 | 10,720,000 | 4,048,000 | 364,000 | 426,000 | 363,000 | 398,000 | 4,703,000 | 5,728,000 | 5,740,000 | 5,690,000 | 6,064,000 | 5,525,000 | 5,841,000 | 5,986,000 | 6,139,000 | 6,064,000 | 5,977,000 | 5,782,000 | 5,506,000 | 5,597,000 | 5,770,000 | 5,041,000 | 5,096,000 | 5,634,000 | 5,632,000 | 5,580,000 | 6,034,000 | 5,822,000 | 4,834,000 | 5,002,000 | 5,000,000 | 7,710,000 | 5,564,000 | 3,857,000 | 7,019,000 | 31,611,000 | 11,664,000 | 10,977,000 | 13,614,000 | 11,901,000 | 12,401,000 | 13,196,000 | 11,987,000 | 12,341,000 | 12,041,000 | 7,957,000 | 7,847,000 | 7,867,000 |
| foreign currency exchange (gains) losses | 1,100,000 | -503,000 | 1,641,000 | -2,067,000 | -1,680,000 | -1,253,000 | 897,000 | -2,128,000 | -1,761,000 | -15,000 | -286,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| (gains) losses from change in fair market value of equity securities and loan receivable | -334,400,000 | 420,072,500 | -792,888,000 | -422,177,000 | -324,291,000 | -36,425,000 | -978,752,000 | 288,999,000 | 1,338,190,000 | 4,545,117,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| other income | -16,200,000 | -37,200,000 | -19,560,000 | -18,081,000 | -18,143,000 | -34,516,000 | -19,078,000 | -20,446,000 | -16,488,000 | -50,431,000 | -10,592,250 | -3,062,000 | -6,710,000 | -32,597,000 | -10,043,000 | 579,000 | 96,000 | -17,407,000 | -2,971,000 | -1,015,000 | -17,229,000 | -3,273,000 | 865,000 | -4,367,000 | -3,896,000 | -18,696,000 | -7,005,000 | -2,585,000 | -15,858,000 | -11,145,000 | 2,414,000 | -1,436,000 | -11,757,000 | -1,418,000 | -1,026,000 | -1,439,000 | -11,208,000 | -1,177,000 | -2,088,000 | -732,000 | -7,107,000 | -1,153,000 | -3,347,000 | -613,000 | -8,388,000 | -661,000 | -2,055,000 | -667,000 | -8,644,000 | -1,400,000 | -7,191,000 | -1,511,000 | -6,731,000 | -6,450,000 | -1,676,000 | -538,000 | -4,418,000 | -193,000 | -5,687,000 | -7,495,000 |
| income before income taxes | 414,000,000 | 83,400,000 | -358,395,750 | 861,620,000 | -2,786,281,000 | 491,078,000 | -319,624,000 | 137,102,000 | -1,500,427,000 | 84,829,000 | -1,450,766,250 | -209,168,000 | -1,222,880,000 | -4,371,017,000 | -2,038,055,000 | 5,022,226,000 | 1,156,775,000 | 1,297,203,000 | 1,078,533,000 | 1,684,461,000 | 1,245,945,000 | 898,699,000 | 699,430,000 | -335,216,000 | 769,601,000 | 1,127,266,000 | -1,041,247,000 | 350,131,000 | 340,086,000 | 863,689,000 | 37,683,000 | 38,855,000 | 1,120,000 | 20,147,000 | -28,187,000 | 22,688,000 | 26,864,000 | 20,195,000 | 54,198,000 | 25,415,000 | 39,540,000 | 26,694,000 | 45,746,000 | 22,476,000 | 48,797,000 | 14,538,000 | 44,510,000 | -5,216,000 | 47,661,000 | 22,449,000 | 57,339,000 | 53,394,000 | 66,019,000 | 46,179,000 | 73,909,000 | 55,773,000 | 57,819,000 | |||
| (benefit from) benefit from income taxes | -96,200,000 | 76,296,250 | -208,448,000 | 72,866,000 | -30,845,000 | -15,867,000 | -215,485,000 | -369,637,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income | 317,800,000 | 64,000,000 | -715,802,000 | 653,172,000 | -2,165,486,000 | 383,916,000 | 349,708,000 | 106,257,000 | -1,162,251,000 | 68,962,000 | 833,494,000 | -164,232,000 | -927,184,000 | -3,369,613,000 | -1,573,659,000 | 3,928,033,000 | 914,114,000 | 977,414,000 | 839,102,000 | 1,314,824,000 | 966,429,000 | 685,912,000 | 553,486,000 | -258,816,000 | 598,810,000 | 865,195,000 | -828,529,000 | 269,326,000 | 268,043,000 | 656,774,000 | 77,408,000 | 27,393,000 | 5,035,000 | 12,413,000 | -20,570,000 | 18,405,000 | 18,014,000 | 12,276,000 | 15,902,750 | 17,370,000 | 28,423,000 | 17,818,000 | 26,495,000 | 27,971,000 | 25,671,000 | |||||||||||||||
| yoy | -114.68% | -83.33% | -304.69% | 514.71% | 86.32% | 456.71% | -58.04% | -164.70% | 25.35% | -102.05% | -152.97% | -104.18% | -201.43% | -444.75% | -287.54% | 198.75% | -5.41% | 42.50% | 51.60% | -608.01% | 61.39% | -20.72% | -166.80% | -196.10% | 123.40% | 31.73% | -1170.34% | 883.19% | 5223.59% | 5191.02% | -476.32% | 48.83% | -72.05% | 1.12% | -229.35% | 5.96% | -36.62% | -31.10% | ||||||||||||||||||||||
| qoq | 396.56% | -108.94% | -209.59% | -130.16% | -664.05% | 9.78% | 229.12% | -109.14% | -1785.35% | -91.73% | -607.51% | -82.29% | -72.48% | 114.13% | -140.06% | 329.71% | -6.48% | 16.48% | -36.18% | 36.05% | 40.90% | 23.93% | -313.85% | -143.22% | -30.79% | -204.43% | -407.63% | 0.48% | -59.19% | 748.46% | 182.58% | 444.05% | -59.44% | -160.35% | -211.76% | 2.17% | 46.74% | -22.81% | -8.45% | -38.89% | 59.52% | -5.28% | 8.96% | |||||||||||||||||
| net income margin % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings (losses) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per basic share | 11.67 | 2.29 | 13.46 | 2.33 | 27.81 | -5.52 | -31.12 | -112.57 | -52.96 | 131.75 | 30.71 | 32.77 | 28.11 | 44.24 | 32.59 | 22.97 | 18.51 | -8.68 | 20.08 | 29.03 | -27.79 | 9.02 | 8.99 | 22.05 | 2.61 | 0.92 | 0.17 | 0.42 | -0.7 | 0.63 | 0.61 | 0.42 | 0.545 | 0.59 | 0.98 | 0.61 | ||||||||||||||||||||||||
| weighted-average common shares - basic | 27,226 | 27,941 | 28,518 | 29,209 | 29,102 | 29,596 | 29,785 | 29,733 | 29,794 | 29,933 | 29,831 | 29,814 | 29,764 | 29,823 | 29,768 | 29,721 | 29,652 | 29,865 | 29,843 | 29,831 | 29,814 | 29,801 | 29,836 | 29,863 | 29,814 | 29,787 | 29,655 | 29,660 | 29,613 | 29,580 | 29,440 | 29,444 | 29,398 | 29,364 | 29,186 | 29,195 | 29,136 | 29,092 | 28,876 | 28,884 | 28,826 | 28,791 | 28,586 | 28,603 | 28,538 | 28,494 | 28,290 | 28,312 | 28,250 | 28,201 | 28,031 | 28,072 | 28,014 | |||||||
| diluted earnings (losses) per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per diluted share | 11.67 | 2.29 | -9.973 | 23.34 | 13.45 | 11.81 | 3.64 | 2.32 | 27.81 | -5.52 | -31.12 | -112.57 | -52.2 | 129.96 | 30.32 | 32.38 | 27.74 | 43.64 | 32.15 | 22.72 | 18.3 | -8.68 | 19.86 | 28.74 | -27.4 | 8.89 | 8.87 | 21.77 | 2.58 | 0.91 | 0.17 | 0.41 | -0.7 | 0.62 | 0.61 | 0.42 | 0.543 | 0.59 | 0.97 | 0.61 | ||||||||||||||||||||
| weighted-average common shares - diluted | 27,228 | 27,955 | 27,985 | 28,537 | 29,209 | 29,223 | 29,747 | 29,785 | 29,733 | 29,794 | 29,933 | 30,208 | 30,224 | 30,148 | 30,186 | 30,160 | 30,128 | 30,058 | 30,196 | 30,184 | 29,831 | 30,154 | 30,104 | 30,228 | 30,292 | 30,219 | 30,171 | 30,034 | 30,052 | 30,006 | 29,911 | 29,646 | 29,671 | 29,589 | 29,506 | 29,409 | 29,439 | 29,381 | 29,289 | 29,133 | 29,141 | 29,092 | 29,059 | 28,906 | 28,603 | 28,868 | 28,817 | 28,642 | 28,645 | 28,610 | 28,553 | 28,468 | 28,456 | 28,495 | ||||||
| foreign currency exchange gains | -2,700,000 | -1,699,000 | -1,954,000 | -2,347,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| gains from change in fair market value of equity securities and loan receivable | -31,800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit from income taxes | -19,400,000 | 620,795,000 | -107,162,000 | 338,176,000 | -265,298,000 | 44,936,000 | 295,696,000 | 1,001,404,000 | 464,396,000 | -1,094,193,000 | -242,661,000 | -319,789,000 | -279,516,000 | -212,787,000 | -89,115,500 | 76,400,000 | -170,791,000 | -262,071,000 | -89,940,750 | -80,805,000 | -206,915,000 | 39,725,000 | -11,462,000 | -7,734,000 | 7,617,000 | -4,283,000 | -8,850,000 | -7,919,000 | -4,716,000 | -8,045,000 | -11,117,000 | -8,876,000 | -6,709,000 | -10,967,000 | -17,166,000 | -7,870,000 | -14,374,000 | -1,883,000 | -12,987,000 | -2,929,000 | -15,372,000 | -11,023,000 | -17,454,000 | -15,235,000 | -14,708,000 | -9,911,000 | -17,797,000 | -10,823,000 | 7,137,000 | 10,041,000 | ||||||||||
| basic earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic earnings loss per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per share | -25.47 | 23.37 | -76.26 | -8.408 | 3.65 | -39.59 | 1.22 | 0.68 | 1.48 | 1.5 | 1.71 | 1.1 | 2.11 | 1.63 | 1.43 | |||||||||||||||||||||||||||||||||||||||||||||
| weighted-average common shares | 28,214 | 27,949 | 28,395 | 29,355 | 26,881 | 26,715 | 26,657 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| losses from change in fair market value of equity securities and loan receivable | 2,895,355,000 | 1,595,442,000 | 17,525,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| basic and diluted loss per share: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| foreign currency exchange losses | 783,250 | 4,364,000 | 2,211,000 | 2,232,000 | 71,000 | -707,000 | 776,000 | 774,000 | 928,000 | -1,166,000 | 898,000 | 1,280,000 | 950,000 | 672,000 | 1,254,000 | 1,917,000 | 3,363,000 | 2,516,000 | 1,789,000 | 894,000 | 1,210,000 | 1,237,000 | 1,129,000 | 3,806,000 | 1,529,500 | 3,667,000 | ||||||||||||||||||||||||||||||||||
| change in fair market value of equity securities | -1,769,688,250 | -4,868,659,000 | -1,030,691,000 | -1,179,403,000 | -904,316,000 | -1,580,350,000 | -1,183,488,000 | -827,671,000 | -645,988,000 | 390,620,000 | -716,389,000 | -1,059,230,000 | 814,109,000 | -318,007,000 | -286,398,000 | -815,934,000 | ||||||||||||||||||||||||||||||||||||||||||||
| foreign currency exchange losses (gains) | 1,233,000 | 2,227,500 | 2,166,000 | 2,938,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| benefit for income taxes | -72,043,000 | 3,915,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| impairment loss on long-lived asset | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income including noncontrolling interests | 39,037,000 | 11,509,000 | 31,631,000 | 6,668,000 | 30,136,000 | -7,099,000 | 34,674,000 | 19,520,000 | 41,967,000 | 42,371,000 | 48,565,000 | 30,944,000 | 59,201,000 | 45,862,000 | 40,022,000 | |||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to noncontrolling interests | 61,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to bio-rad | 39,037,000 | 11,509,000 | 31,631,000 | 6,668,000 | 30,136,000 | -7,099,000 | 34,674,000 | 19,499,000 | 42,046,000 | 42,384,000 | 48,343,000 | 31,005,000 | 59,239,000 | 45,897,000 | 40,048,000 | |||||||||||||||||||||||||||||||||||||||||||||
| net income per basic share attributable to bio-rad | 1.35 | 0.4 | 1.1 | 0.23 | 1.05 | -0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income per diluted share attributable to bio-rad | 1.34 | 0.39 | 1.09 | 0.23 | 1.04 | -0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| foreign exchange losses | 2,737,000 | 2,843,000 | 3,330,000 | 865,000 | 1,528,000 | 1,532,000 | 448,000 | 1,619,000 | 1,441,000 | 1,710,000 | 6,346,000 | 2,744,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| net (income) loss attributable to noncontrolling interests | -21,000 | -222,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| net income (income) attributable to noncontrolling interests | -37,000 | 13,000 | 38,000 | 35,000 | 26,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| product research and development expense | 37,489,000 | 33,145,000 | 34,754,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| foreign exchange (gains) losses | 2,593,000 | 257,000 | -398,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income before taxes and minority interests | 39,382,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| minority interests in earnings of consolidated subsidiaries | -2,064,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| the accompanying notes are an integral part of these condensed consolidated financial statements. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| income before taxes | 35,108,000 | 35,712,000 |
We provide you with 20 years income statements for Bio-Rad Laboratories stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Bio-Rad Laboratories stock. Explore the full financial landscape of Bio-Rad Laboratories stock with our expertly curated income statements.
The information provided in this report about Bio-Rad Laboratories stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.